Journal article
Inhibitor development in non-severe haemophilia across Europe
Abstract
Evidence about inhibitor formation in non-severe haemophilia and the potential role for clotting factor concentrate type is scant. It was the aim of this study to report inhibitor development in non-severe haemophilia patients enrolled in the European Haemophilia Safety Surveillance (EUHASS) study. Inhibitors are reported quarterly and total treated patients annually. Incidence rates and 95% confidence intervals (95% CI) were calculated …
Authors
Fischer K; Iorio A; Lassila R; Peyvandi F; Calizzani G; Gatt A; Lambert T; Windyga J; Gilman EA; Hollingsworth R
Journal
Thrombosis and Haemostasis, Vol. 114, No. 04, pp. 670–675
Publisher
Thieme
Publication Date
2015
DOI
10.1160/th14-12-1044
ISSN
0340-6245